Empyrean Medical Systems Deploys First Artemis 320 Irradiator

The system arrives during a period of transition for biological research facilities. It is the first platform to satisfy the Department of Homeland Security’s Cesium Replacement Program requirements while maintaining the rigorous standards necessary for oncology and immunology studies. By replacing older technology with conformal irradiation, the device allows institutions to conduct complex bone marrow transplantation research and other hematologic studies with greater consistency.

Christopher J. Bakkenist, Chair in Radiation Oncology Research, noted that the machine fills a significant gap in the current market, providing the high-energy output required for specialized medical studies. For research teams, the system replaces manual recording with a record-and-verify interface, reducing the potential for human error. Empyrean Medical Systems is currently negotiating further installations, aiming to establish the Artemis™ 320 as the industry standard for preclinical data transparency and experimental fidelity.